Top

Published in:

01-01-2013

Patient selection for mechanical circulatory support

Authors: Nisha A. Gilotra, Stuart D. Russell

Published in: Heart Failure Reviews | Issue 1/2013

Abstract

Heart failure continues to be associated with high morbidity and mortality. Over the past decade, left ventricular assist devices have been shown to improve the survival and quality of life. However, it is quite clear that very sick patients do not do as well, and it is therefore imperative to select patients at the proper time. In this article, we review both the indications for considering left ventricular assist device therapy as well as discuss the considerations and therapy that should be done pre-operatively to possibly improve post-insertion outcomes.

Writing Group Members, Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES et al (2012) Executive summary: heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation 125(1):188-97

Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348(20):2007–2018PubMedCrossRef

Hershberger RE, Nauman D, Walker TL, Dutton D, Burgess D (2003) Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail 9(3):180–187PubMedCrossRef

Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN III (2007) INTrEPID Investigators. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID trial. J Am Coll Cardiol 50(8):741–747PubMedCrossRef

Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Hertz MI (2011) The registry of the international society for heart and lung transplantation: twenty-eighth adult heart transplant report–2011. J Heart Lung Transplant 30(10):1078–1094PubMedCrossRef

Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG et al (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345(20):1435–1443PubMedCrossRef

Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM et al (2007) Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357(9):885–896PubMedCrossRef

Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM III, Long JW et al (2009) Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361(23):2241–2251PubMedCrossRef

Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park S, John R, Conte JV et al (2010) Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 55(17):1826–1834PubMedCrossRef

10.

Aaronson KD. Evaluation of the HeartWare ventricular assist system for the treatment of advanced heart failure: results of the ADVANCE bridge to transplant trial. American Heart Association Annual Conference Proceedings; November 2010

11.

Boyle AJ, Ascheim DD, Russo MJ, Kormos RL, John R, Naka Y, Gelijns AC, Hong KN, Teuteberg JJ (2011) Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant 30(4):402–407PubMedCrossRef

12.

Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK (2009) INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 28(6):535–541PubMedCrossRef

13.

National Coverage Determination for Artificial Hearts and Related Devices (20.9) [Internet]; c2009 [cited 2012 January 29]. Available from: https://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=246&ncdver=5&NCAId=187&NcaName=Ventricular+Assist+Devices+as+Destination+Therapy&IsPopup=y&bc=AAAAAAAAIAAA&

14.

Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA et al (2009) Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American heart association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation 119(14):1977–2016PubMedCrossRef

15.

Mancini D, Lietz K (2010) Selection of cardiac transplantation candidates in 2010. Circulation 122(2):173–183PubMedCrossRef

16.

Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR (1991) Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83(3):778–786PubMedCrossRef

17.

Francis DP, Shamim W, Davies LC, Piepoli MF, Ponikowski P, Anker SD, Coats AJ (2000) Cardiopulmonary exercise testing for prognosis in chronic heart failure: Continuous and independent prognostic value from VE/VCO(2) slope and peak VO(2). Eur Heart J 21(2):154–161PubMedCrossRef

18.

Poggio R, Arazi HC, Giorgi M, Miriuka SG (2010) Prediction of severe cardiovascular events by VE/VCO2 slope versus peak VO2 in systolic heart failure: a meta-analysis of the published literature. Am Heart J 160(6):1004–1014PubMedCrossRef

19.

Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M (2006) Listing criteria for heart transplantation: international society for heart and lung transplantation guidelines for the care of cardiac transplant candidates–2006. J Heart Lung Transpl 25(9):1024–1042CrossRef

20.

Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM (1997) Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95(12):2660–2667PubMedCrossRef

21.

Lund LH, Aaronson KD, Mancini DM (2005) Validation of peak exercise oxygen consumption and the heart failure survival score for serial risk stratification in advanced heart failure. Am J Cardiol 95(6):734–741PubMedCrossRef

22.

Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD et al (2006) The seattle heart failure model: prediction of survival in heart failure. Circulation 113(11):1424–1433PubMedCrossRef

23.

Ketchum ES, Moorman AJ, Fishbein DP, Mokadam NA, Verrier ED, Aldea GS, Andrus S, Kenyon KW, Levy WC (2010) Predictive value of the seattle heart failure model in patients undergoing left ventricular assist device placement. J Heart Lung Transpl 29(9):1021–1025CrossRef

24.

Teuteberg JJ, Lewis EF, Nohria A, Tsang SW, Fang JC, Givertz MM, Jarcho JA, Mudge GH, Baughman KL, Stevenson LW (2006) Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J Card Fail 12(1):47–53PubMedCrossRef

25.

O’Connor CM, Hasselblad V, Mehta RH, Tasissa G, Califf RM, Fiuzat M, Rogers JG, Leier CV, Stevenson LW (2010) Triage after hospitalization with advanced heart failure: the ESCAPE (evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness) risk model and discharge score. J Am Coll Cardiol 55(9):872–878PubMedCrossRef

26.

Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O’Connor CM, Califf RM, Adams KF Jr (2007) Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 9(10):1064–1069PubMedCrossRef

27.

Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ (2005) ADHERE Scientific Advisory Committee, study group, and investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293(5):572–580PubMedCrossRef

28.

Russell SD, Miller LW, Pagani FD (2008) Advanced heart failure: a call to action. Congest Heart Fail 14(6):316–321PubMedCrossRef

29.

Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB (2010) Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 29(1):1–10PubMedCrossRef

30.

Deng MC, Loebe M, El-Banayosy A, Gronda E, Jansen PG, Vigano M, Wieselthaler GM, Reichart B, Vitali E, Pavie A et al (2001) Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation 103(2):231–237PubMedCrossRef

31.

Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW (2007) Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116(5):497–505PubMedCrossRef

32.

Clark AL, Loebe M, Potapov EV, Egerer K, Knosalla C, Hetzer R, Anker SD (2001) Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight. Eur Heart J 22(24):2275–2283PubMedCrossRef

33.

Mano A, Fujita K, Uenomachi K, Kazama K, Katabuchi M, Wada K, Terakawa N, Arai K, Hori Y, Hashimoto S et al (2009) Body mass index is a useful predictor of prognosis after left ventricular assist system implantation. J Heart Lung Transplant 28(5):428–433PubMedCrossRef

34.

Lockard KI, Degore L, Schwarm P, Winowich S, O’Shea G, Siegenthaler M, Simon M, Kormos RL, Teuteberg JJ (2009) Lack of improvement in prealbumin at 2 weeks predicts a poor outcome after mechanical circulatory support. J Heart Lung Transpl 28(2):S66CrossRef

35.

Holdy K, Dembitsky W, Eaton LL, Chillcott S, Stahovich M, Rasmusson B, Pagani F (2005) Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transpl 24(10):1690–1696CrossRef

36.

Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, Grimm M, Wolner E, Wieselthaler GM (2009) Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 87(4):1072–1078PubMedCrossRef

37.

Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L et al (2009) Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the heartmate II left ventricular assist device. Circulation 120(23):2352–2357PubMedCrossRef

38.

Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, Starling RC, Chen L, Boyle AJ, Chillcott S et al (2010) Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transpl 29(4 Suppl):S1–39CrossRef

39.

Fitzpatrick JR III, Frederick JR, Hsu VM, Kozin ED, O’Hara ML, Howell E, Dougherty D, McCormick RC, Laporte CA, Cohen JE et al (2008) Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplt 12:1286–1292CrossRef

40.

Matthews JC, Koelling TM, Pagani FD, Aaronson KD (2008) The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 51(22):2163–2172PubMedCrossRef

41.

Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS et al (2010) Right ventricular failure in patients with the heartmate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 139(5):1316–1324PubMedCrossRef

42.

John R, Liao K, Lietz K, Kamdar F, Colvin-Adams M, Boyle A, Miller L, Joyce L (2007) Experience with the levitronix centrimag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg 134(2):351–358PubMedCrossRef

Title: Patient selection for mechanical circulatory support
Authors: Nisha A. Gilotra
Stuart D. Russell
Publication date: 01-01-2013
Publisher: Springer US
Published in: Heart Failure Reviews / Issue 1/2013
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-012-9316-0

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Patient selection for mechanical circulatory support

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2013

Should high-intensity-aerobic interval training become the clinical standard in heart failure?

Diastolic ventricular support with cardiac support devices: an alternative approach to prevent adverse ventricular remodeling

A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure

Assessment and management of aortic valve disease in patients with left ventricular dysfunction

Surgical approaches to left ventricular reconstruction: a matter of perspective

Mechanical circulatory support: devices, outcomes and complications

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page